Article - 04/02/2013 capmatch medical – financing network for life sciences start-ups and investors “capmatch medical” was specifically designed for young medical device and biotech companies that are seeking capital from investors in Europe. Combined with professional coaching and process management, capmatch medical’s matching approach improves the chances of successful matchmaking between companies and dedicated investors. https://www.gesundheitsindustrie-bw.de/en/article/news/capmatch-medical-financing-network-for-life-sciences-start-ups-and-investors
Article - 04/02/2013 Combining bio- and medtech for the diagnosis of cardiac diseases The Department of Cardiology at Heidelberg University Hospital and Siemens Corporate Technology have been working together since 2011 to develop new software that improves the diagnosis of heart diseases. The new software analyses and manages data related to the genetic causes of cardiomyopathy and presents the data to physicians in a clear manner. Specific microRNAs in the blood of patients have the potential of being used as new biomarkers,…https://www.gesundheitsindustrie-bw.de/en/article/news/combining-bio-and-medtech-for-the-diagnosis-of-cardiac-diseases
Article - 31/12/2012 Diagnosis of myocardial infarction: a drop of blood is all that is required Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial…https://www.gesundheitsindustrie-bw.de/en/article/news/diagnosis-of-myocardial-infarction-a-drop-of-blood-is-all-that-is-required
Dossier - 20/12/2012 Medical technology – serving healthcare Modern healthcare would be impossible without medical technology. The achievements in medical technology are indispensable for our health and quality of life. The range of medical technology available covers surgical instruments and implants to diagnostic methods and medical devices.https://www.gesundheitsindustrie-bw.de/en/article/dossier/medical-technology-serving-healthcare
Article - 17/12/2012 The ablation of nerves along the renal artery – a novel treatment option in the field of cardiology High blood pressure can normally be treated effectively with medicines. However, some patients do not respond to medicinal treatment despite several different drugs being used. Renal denervation (RDN), a novel catheter-based procedure, seems to have become a promising alternative to controlling hypertension with drugs. Professor Dr. Axel Bauer from the Tübingen University Hospital believes that this method can even be used for a much wider range…https://www.gesundheitsindustrie-bw.de/en/article/news/the-ablation-of-nerves-along-the-renal-artery-a-novel-treatment-option-in-the-field-of-cardiology
Article - 10/12/2012 MicroMol GmbH and “the fine art of life science” MicroMol GmbH carries out microbiological, molecular and cell biological analyses, is active in research and development, performs validations and produces and sells laboratory products for the life sciences industry. This brief description reflects a broad product and service portfolio that addresses a wide range of different clients, including companies in the pharmaceutical and chemical industries and in the medical technology, industrial…https://www.gesundheitsindustrie-bw.de/en/article/news/micromol-gmbh-and-the-fine-art-of-life-science
Press release - 26/11/2012 Textile pressure ulcer prevention Immobile patients are in constant danger of developing pressure ulcers on the skin. Empa, Schoeller Medical and the Swiss Paraplegic Centre have worked together to develop a special sheet that is gentle on the skin and helps to make patients more comfortable.https://www.gesundheitsindustrie-bw.de/en/article/press-release/textile-pressure-ulcer-prevention
Article - 29/10/2012 Tilman Schäffer: Biology and medicine – from the point of view of physics Tilman Schäffer at the University of Tübingen creates a bridge between physics, biology and medicine. His speciality is innovative microscopic detection methods such as atomic force microscopy. In addition to application, Schäffer is working on improving scanning probe microscopy instrumentation and methods. https://www.gesundheitsindustrie-bw.de/en/article/news/tilman-schaeffer-biology-and-medicine-from-the-point-of-view-of-physics
Article - 22/10/2012 syneed imaging: precise visualisation of functional tissue properties Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of…https://www.gesundheitsindustrie-bw.de/en/article/news/syneed-imaging-precise-visualisation-of-functional-tissue-properties
Press release - 11/10/2012 Novalung GmbH receives EU grant for the development of a cell-coated artificial lung The AmbuLung (Ambulatory Bioartificial Lung) project is a milestone in the history of artificial organs and is being subsidized by the EU with a total of 5.6 Million Euros - 3 Million Euros will go to Novalung as the Coordinator of the European development consortium. The joint developmental goal is the AmbuLung, which will allow patients to remain awake, mobile and active despite lung failure. The core innovation within the framework of the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/novalung-gmbh-receives-eu-grant-for-the-development-of-a-cell-coated-artificial-lung
Article - 10/09/2012 EU cooperations at the interface of research and industry It is also in the interest of small companies to look beyond their national borders: biotechnology and medical technology specialists in neighbouring European countries offer excellent prospects to German companies – and vice versa. Regional life sciences networks help establish and intensify contacts and collaborative activities between international partners.https://www.gesundheitsindustrie-bw.de/en/article/news/eu-cooperations-at-the-interface-of-research-and-industry
Article - 06/08/2012 Database instead of a book – software facilitates diagnosis of liver diseases The bachelor’s theses of Matthias Hillert and Pascal Laube, students at the Konstanz University of Applied Sciences (HTWG), involved the development of a computer programme that facilitates the analysis of computed tomography images of the liver by comparing them to similar images stored in a database. It is a tool that has the potential to be used in other areas, such as the identification of bone tumours.https://www.gesundheitsindustrie-bw.de/en/article/news/database-instead-of-a-book-software-facilitates-diagnosis-of-liver-diseases
Press release - 16/07/2012 Winners of the "Science2Start" ideas competition honoured BioRegio STERN Management GmbH honoured the three winners of the regional "Science2Start" ideas competition last Thursday evening. The award ceremony was part of the traditional summer soirée given by BioRegio STERN Management GmbH in collaboration with TTR Technologieparks Tübingen-Reutlingen GmbH, the Verein zur Förderung der Biotechnologie und der Medizintechnik e.V. (Society for the Promotion of Biotechnology and Medical Technology)…https://www.gesundheitsindustrie-bw.de/en/article/press-release/winners-of-the-science2start-ideas-competition-honoured
Press release - 06/07/2012 Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/medicyte-is-receiving-4-2-mio-euros-from-the-european-union-seventh-framework-programm
Press release - 10/05/2012 BVMed propounds Annual Report The German Medical Technology Association BVMed advocates for a better coordination and promotion of advances in medical technology. BVMed the German Medical Technology Association represents more than 230 manufacturers and trade companies in the medical technology sector. Medtech production amounts to about 20 billion euros with 175.000 employees in Germany. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bvmed-propounds-annual-report
Press release - 08/05/2012 BIOPRO Baden-Württemberg: 10 years More than 120 invited guests came to Stuttgart on 2nd May 2012 to discuss the potential of biotechnology in Baden-Württemberg – and to celebrate! Speakers praised BIOPRO and entertained the audience with anecdotes about the last 10 years as well as congratulating Dr. Ralf Kindervater, CEO of BIOPRO Baden-Württemberg GmbH, for the committed and sustainable work his organization has done over the last ten years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biopro-baden-wuerttemberg-10-years
Article - 30/04/2012 BioValley Meet & Match event: "Orthopaedic Implants" The sixth Meet & Match event was held at the International Space University in Illkirch close to Strasbourg on 29th March 2012. The meeting focused on “Orthopaedic Implants”. Science and industry representatives from the trinational BioValley gave 21 presentations focusing on a broad range of different aspects. The event was organized by the BioValley Matchmaking Team with the support of BIOPRO Baden-Württemberg GmbH. https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-meet-match-event-orthopaedic-implants
Dossier - 26/03/2012 Nanobiotechnology The term nanotechnology is known by well over 50 of Germans especially since the lotus effect hit the headlines in the late 1990s. Around the turn of the millennium bio was inserted between nano and technology and nanobiotechnology has since taken up more and more room in the headlines as well as requiring major financial investment. What is nanobiotechnology what is the difference between nanotechnology and nanobiotechnology and where and what…https://www.gesundheitsindustrie-bw.de/en/article/dossier/nanobiotechnology
Press release - 14/03/2012 Three cluster regions with a common goal At MEDTEC Europe 2012, the leading medical platform in Europe held in Stuttgart from 13th to 15th March 2012, the three life sciences organisations BIOPRO Baden-Württemberg GmbH, Health Technology Cluster – Clusterland Oberösterreich GmbH and Human.technology Styria GmbH signed a “Memorandum of Understanding (MoU”) to seal their future cooperation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/three-cluster-regions-with-a-common-goal
Dossier - 12/03/2012 Regenerative medicine makes use of patients’ own resources Regenerative medicine offers new therapeutic options for many diseases in which organ function or structure are damaged or lost. The majority of regenerative therapies involve cell-based methods that are often combined with innovative biomaterials. Regenerative therapies combine know-how from the biosciences with state-of-the-art medical technology and also benefit from progress in the engineering and material sciences.https://www.gesundheitsindustrie-bw.de/en/article/dossier/regenerative-medicine-makes-use-of-patients-own-resources
Article - 20/02/2012 Microporation: an innovative laser replaces jabs People who are afraid of needles now have something to celebrate: hypodermic needles, which have long been the key instrument for administering drugs used to treat allergies and diseases as well as for vaccinations, now have a serious competitor. The minimally invasive P.L.E.A.S.E. ® platform developed by Pantec Biosolutions AG combines a laser device and stick-on patches to deliver drugs transdermally and painlessly into the bloodstream. The…https://www.gesundheitsindustrie-bw.de/en/article/news/microporation-an-innovative-laser-replaces-jabs
Article - 20/02/2012 Vektor-Pharma: a start-up that merges pharmacy and mechanical engineering The company Vektor-Pharma plans to develop and manufacture medicated adhesive patches and therapeutic films. Pharmacists and mechanical engineers have entered into a kind of symbiotic relationship and are currently working on the establishment of a successful business. Interdisciplinary synergy is key to developing such transdermal therapeutic systems TTS more quickly effectively and cheaply than any one discipline would be able to do on its own.…https://www.gesundheitsindustrie-bw.de/en/article/news/vektor-pharma-a-start-up-that-merges-pharmacy-and-mechanical-engineering
Article - 06/02/2012 Ten outstanding ideas in biotechnology and medical technology The results of the feasibility studies funded under the Idea Competition in Biotechnology and Medical Technology were presented in the Haus der Wirtschaft in Stuttgart between 16th and 18th January 2012. Ten of the 42 project ideas were recommended for further funding.https://www.gesundheitsindustrie-bw.de/en/article/news/ten-outstanding-ideas-in-biotechnology-and-medical-technology
Article - 30/01/2012 Silicone application in medical technology Silicone is flexible, biocompatible and heat-resistant, characteristics that make organosilicone compounds ideal for a wide range of applications in medical technology. Up until now, the broad application of such compounds has been hampered chiefly by the high surface friction of silicone. The Reutlingen-based company Silcos GmbH has developed special methods for the treatment of surfaces that considerably improve the compound's range of…https://www.gesundheitsindustrie-bw.de/en/article/news/silicone-application-in-medical-technology
Article - 23/01/2012 Peter Rodemann – a career in radiobiology Prof. Dr. H. Peter Rodemann has been head of the Division of Radiobiology and Molecular Environmental Research at Tübingen University Hospital for around 20 years. He has been awarded numerous prizes for his outstanding achievements, particularly during the second half of 2011 when he was awarded the Ulrich Hagen Prize by the German Society for Biological Radiation Research as well as being elected member of the German Academy of Sciences…https://www.gesundheitsindustrie-bw.de/en/article/news/peter-rodemann-a-career-in-radiobiology